Healthcare & Pharmaceuticals
Miras Legal has advised and litigated on behalf of several clients in the healthcare and pharmaceutical industries. Miras Legal has been instrumental in achieving remarkable successes, in the fields of pharmaceutical and medical device registrations, agents, patent, distribution network structuring, establishment of primary and secondary healthcare providers, and claims relating to their operations.
We advised a leading Swiss pharmaceutical company on restructuring its distribution network in Kuwait and transferring product registration to the Ministry of Health (MoH).
We successfully obtained regulatory approvals from MoH allowing the registration of generic drugs newly introduced in the Kuwaiti market by a leading Jordanian pharmaceutical company.
We won a significant victory for a Kuwaiti medical devices company against its German principal in an appeal relating to unlawful agency termination. In that case, the appellate court awarded our client the claimed compensation in a great come-back after the dismissal of the client’s claim represented in the court of first instance by a competitor law firm.
We represent one of Kuwait’s key private hospitals in all elements related to its B.O.T contract, shareholder relationships, medical devices supply, and disputes arising from medical errors.
We represent a Kuwaiti pharmaceutical company in a dispute over due payables from the Ministry of Health.
We represent a leading industrial union against a Kuwaiti governmental body in a contentious dispute relating to an industrial national initiative to support the State of Kuwait in mitigating the impacts of Covid-19 pandemic. One of our partners served as the legal advisor to the Kuwait Investment Authority (the State of Kuwait Sovereign Wealth Fund) on the establishment of Kuwait Health Assurance Company “KHAC” (also known as “Dhaman”) with a capital of USD 815 Million on all aspects of the transaction, starting with legal compliance of project’s technical issues, bid document preparation, and company establishment in coordination with various governmental entities.
One of our partners was successful in obtaining a favorable compensation award for a leading Kuwaiti pharmaceutical company against major international pharmaceutical corporations including Abbott and Bayer.
